Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Biofrontera's price to book ratio was 1.9× on Oct 19, 2026, against 1.4× a year earlier. Over the last 4 years it ranged from 0.3× to 20.4×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 1.9× | −18.5 |
| 2025 | Jul 31, 2025 | 20.4× | +19.1 |
| 2024 | Dec 31, 2024 | 1.3× | −2.4 |
| 2023 | Dec 29, 2023 | 3.6× | +2.7 |
| 2022 | Dec 30, 2022 | 1.0× | −5.1 |
| 2021 | Oct 29, 2021 | 6.1× | – |